CU Anschutz Received $120 Million for Trauma Research

The University of Colorado Anschutz campus in Aurora secured a federal grant to study innovative treatments for bleeding.

Updated on Oct. 13, 2026 in Financial Aid

CU Anschutz Received $120 Million for Trauma Research

Live Poll

Should federal research prioritize the development of synthetic alternatives to traditional donated blood?

The Defense Advanced Research Projects Agency has awarded the University of Colorado Anschutz up to $120 million to lead a major bleeding research initiative. This effort aims to reduce preventable trauma deaths by developing alternatives to traditional blood supplies.

Why it matters

Bleeding remains the leading cause of preventable death following trauma, making the discovery of new treatment technologies a critical public health priority. By evaluating diverse products, this research could significantly strengthen the national blood supply.

The university will receive $120 million in funding over a three-year period to assess 11 different bleeding treatment products. This grant marks the largest federal research award the campus has secured since 2006.

The players

University of Colorado Anschutz

This Aurora-based medical campus serves as a major research hub and academic partner for clinical health systems.

Defense Advanced Research Projects Agency

This federal agency is responsible for the development of emerging technologies for use by the United States military.

UCHealth

This non-profit health system operates multiple hospitals and collaborates with university researchers on clinical trials.

The details

The RAPIID program utilizes an Other Transaction agreement to allow for flexible project scaling as research priorities shift. Researchers will collaborate with UCHealth on clinical trials to confirm that new products meet safety and performance standards.

2006: The campus was established.
October 13, 2026: The award was officially announced.
Year 1: Researchers will focus on laboratory work and trial preparation.
Three-year period: The duration of the grant funding.

Culture Shift

The project operates within the RAPIID program, which serves as a benchmark for how federal agencies structure large-scale medical innovation. This collaboration mirrors a growing trend in institutional research where academic centers partner directly with defense agencies to expedite life-saving solutions.

Residents in Aurora may see an increase in clinical trial opportunities through the collaboration with UCHealth. The research could eventually lead to improved emergency medical care and faster, more reliable treatment protocols for trauma injuries.

The takeaway

This funding represents a significant investment in trauma care that could shift standard medical responses to major injuries. Implementing these new technologies could eventually save lives by providing alternatives to traditional donated blood during emergencies.